<SEC-DOCUMENT>0001299933-18-000144.txt : 20180213
<SEC-HEADER>0001299933-18-000144.hdr.sgml : 20180213
<ACCEPTANCE-DATETIME>20180213125915
ACCESSION NUMBER:		0001299933-18-000144
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20180212
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
FILED AS OF DATE:		20180213
DATE AS OF CHANGE:		20180213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHARLES RIVER LABORATORIES INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001100682
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				061397316
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15943
		FILM NUMBER:		18601524

	BUSINESS ADDRESS:	
		STREET 1:		251 BALLARDVALE ST
		CITY:			WILMINGTON
		STATE:			MA
		ZIP:			01887
		BUSINESS PHONE:		781-222-6000

	MAIL ADDRESS:	
		STREET 1:		251 BALLARDVALE ST
		CITY:			WILMINGTON
		STATE:			MA
		ZIP:			01887

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHARLES RIVER LABORATORIES HOLDINGS INC
		DATE OF NAME CHANGE:	19991208
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>htm_55852.htm
<DESCRIPTION>LIVE FILING
<TEXT>
<!-- CoverPageHeader start -->
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
<TITLE> Charles River Laboratories International, Inc. (Form: 8-K) </TITLE>
</HEAD>
<BODY TEXT="#000000" BGCOLOR="#FFFFFF" ALINK="#0000FF" HLINK="#FF0000" VLINK="#800080">
<A NAME="DOCUMENT_TOP">&nbsp;</A>
<P>
<!-- CoverPageHeader end --><!-- CoverPageTitle START -->
<A NAME="DOCUMENT_TOP">&nbsp;</A>
<HR NOSHADE>
<P>
<P ALIGN="CENTER">
<FONT SIZE="4">
		UNITED STATES<BR>
	SECURITIES AND EXCHANGE COMMISSION
</FONT>
<BR>
<FONT SIZE="2">
	WASHINGTON, D.C. 20549
</FONT>
<P ALIGN="CENTER">
<FONT SIZE="5">
	FORM 8-K
</FONT>
<FONT SIZE="2">

</FONT>
</P>
<P ALIGN="CENTER">
<FONT SIZE="3">
	CURRENT REPORT
</FONT>
</P>
<P ALIGN="CENTER">
<FONT SIZE="2">
	Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934
</FONT>
</P>
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
<TR VALIGN="BOTTOM">
<TD WIDTH="51%">
	&nbsp;
</TD>
<TD WIDTH="5%">
	&nbsp;
</TD>
<TD WIDTH="44%">
	&nbsp;
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	Date of Report (Date of Earliest Event Reported):
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	February 12, 2018
</FONT>
</TD>
</TR>
</TABLE>
<BR>
</CENTER>
<!-- CoverPageTitle END --><!-- CoverPageRegistrant START -->
<P ALIGN="CENTER"><!-- -->
<FONT SIZE="6">
	Charles River Laboratories International, Inc.
</FONT>
<FONT SIZE="2">
<BR>__________________________________________<BR>
	(Exact name of registrant as specified in its charter)
</FONT>
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
<TR VALIGN="BOTTOM">
<TD WIDTH="33%">
	&nbsp;
</TD>
<TD WIDTH="34%">
	&nbsp;
</TD>
<TD WIDTH="33%">
	&nbsp;
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	Delaware
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	001-15943
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	06-1397316
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
_____________________<BR>
	(State or other jurisdiction
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
_____________<BR>
	(Commission
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
______________<BR>
	(I.R.S. Employer
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	of incorporation)
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	File Number)
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	Identification No.)
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	251 Ballardvale St., Wilmington, Massachusetts
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	01887
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
_________________________________<BR>
	(Address of principal executive offices)
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
___________<BR>
	(Zip Code)
</FONT>
</TD>
</TR>
</TABLE>
</CENTER>
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">

<TR VALIGN="BOTTOM">
<TD WIDTH="51%">
	&nbsp;
</TD>
<TD WIDTH="5%">
	&nbsp;
</TD>
<TD WIDTH="44%">
	&nbsp;
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	Registrant&#146;s telephone number, including area code:
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	781-222-6000
</FONT>
</TD>
</TR>
</TABLE>
</CENTER>
<P ALIGN="CENTER">
<FONT SIZE="2">
	Not Applicable
<BR>______________________________________________<BR>
	Former name or former address, if changed since last report
</FONT>
<P ALIGN="CENTER">
<FONT SIZE="2">
	&nbsp;
</FONT>
<!-- CoverPageRegistrant END --><P><FONT SIZE="2">
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:</FONT>
</P>
<P><FONT SIZE="2">
[&nbsp;&nbsp;]&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<br>
[&nbsp;&nbsp;]&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<br>
[&nbsp;&nbsp;]&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<br>
[&nbsp;&nbsp;]&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<br>
</P></FONT><tr><td colspan="3"><!-- PageBreak START -->
<P>

<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<A HREF="#DOCUMENT_TOP">
<U>
<B>
<FONT SIZE="2">Top of the Form</FONT>
</B>
</U>
</A>
</DIV>
<!-- PageBreak END --></td></tr><P><FONT SIZE="2">
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</FONT>
</P>

<P><FONT SIZE="2">
Emerging growth company [&nbsp;&nbsp;]<br>
</P></FONT>
<P><FONT SIZE="2">
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&nbsp;&nbsp;]<br>
</P></FONT><!-- PageBreak START -->
<P>
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<A HREF="#DOCUMENT_TOP">
<U>
<B>
<FONT SIZE="2">Top of the Form</FONT>
</B>
</U>
</A>
</DIV>
<!-- PageBreak END --><!-- Item START -->
<P ALIGN="LEFT">
<FONT SIZE="2">
<B>
	Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
</B>
</FONT>
</P>
<P ALIGN="LEFT">
<FONT SIZE="2">
(c)  On February 13, 2018, Charles River Laboratories International, Inc. (the "Company") announced that Dr. Davide Molho, Corporate Executive Vice President and President, Global Research Models & Services, Safety Assessment and Biologics, will become President and Chief Operating Officer of the Company, effective immediately, and will add Discovery Services to his responsibilities. Dr. Molho will continue to report directly to James C. Foster, Chairman and Chief Executive Officer.<br><br>Dr. Molho, age 48, has a proven track record of outstanding performance, leading many of the Company&#x2019;s businesses through important strategic initiatives during his nearly 20 years with the Company.  Dr. Molho joined the Company in our Italian operations in 1999 and was promoted to Director of Operations for Research Models and Services (RMS) Italy in 2002.  In 2005, his role was expanded to include French RMS operations and in 2007, he became Corporate Vice President, European Research Models and Services, with responsibility for all European RMS operations.  In July 2009, Dr. Molho was promoted to Corporate Senior Vice President, North American & European Research Models and Services, and was promoted to Corporate Executive Vice President and President, Global Research Models and Services in December 2010.  Dr. Molho subsequently assumed the role of Corporate Executive Vice President and President, North American Operations in October 2011 and then Corporate Executive Vice President and President, Global Research Models & Services, Safety Assessment and Biologics in December 2013.  In this role, Dr. Molho was responsible for the global oversight of these businesses and transitioning to a more fully integrated, global organizational structure across North America, Europe, and Asia.<br><br>Dr. Molho received both his D.V. M. degree and his Post Degree in Laboratory Animal Science & Medicine from University of Milan.<br><br>The appointment of Dr. Molho as President and Chief Operating Officer of the Company was not made pursuant to any arrangement or understanding between him and any other person.  Dr. Molho will receive salary, bonus and equity opportunity, and will participate in other benefit and compensation plans, at levels consistent with his position and scope of responsibility.<br><br>On February 13, 2018, the Company issued a press release that discussed the foregoing.  A copy of the press release is attached hereto as Exhibit 99.1.  <br><br><br>(e) On February 13, 2018, Charles River Laboratories International, Inc. (the "Company") announced that it had entered into an employment agreement, effective as of February 12, 2018 (the "Effective Date"), with James C. Foster.  The purpose of the agreement is to benefit from Mr. Foster&#x2019;s decades of experience and unique skill set by promoting the retention of Mr. Foster.  To this end, the employment agreement provides for Mr. Foster&#x2019;s employment as the Chairman and Chief Executive Officer of the Company for a five-year period through February 12, 2023 (the "Employment Term"). <br><br>The employment agreement memorializes Mr. Foster&#x2019;s current compensation arrangements, including his base salary and target annual cash bonus.  The agreement also provides that the vesting schedule and all other terms of the outstanding equity awards held by Mr. Foster as of the Effective Date will remain the same. <br><br>To encourage Mr. Foster&#x2019;s retention, the employment agreement (1) allows Mr. Foster to terminate his employment at any time, with or without notice, in the manner specified in the employment agreement but with the corresponding economic consequence of losing the post-retirement vesting benefits in his existing equity awards and (2) provides that, prior to February 12, 2021, the Company may only terminate Mr. Foster for cause. If Mr. Foster provides notice of the termination of his employment or if, upon or after February 12, 2021, the Company provides notice of the termination of his employment without cause, then the Company may elect to suspend Mr. Foster&#x2019;s active duties and responsibilities and, during the balance of a specified notice period, Mr. Foster will be entitled to receive only his base salary, any previously earned bonus, and the continued vesting of any previously granted equity awards.  If the Company does not exercise its election right, then, during the balance of such notice period, Mr. Foster may continue to actively perform his duties under the employment agreement and will be entitled to his ordinary compensation. <br><br>In addition, if Mr. Foster provides notice of the termination of his employment upon or after February 12, 2021, any equity awards granted to him on or after the Effective Date will continue to be outstanding and become exercisable in the same manner as if his employment had continued. If the Company provides notice of the termination of Mr. Foster&#x2019;s employment without cause upon or after February 12, 2021, Mr. Foster will be entitled to receive such extended equity vesting for any equity awards granted to him on or after the Effective Date, as well as the severance payable to Mr. Foster under the Company&#x2019;s existing Corporate Officer Separation Plan.  Upon the expiration of the Employment Term, Mr. Foster will be eligible for such extended equity vesting for any equity awards granted to him on or after the Effective Date, but will not be entitled to any severance payments or other benefits under the Company&#x2019;s Corporate Officer Separation Plan. <br>Mr. Foster will be subject to post-termination non-competition and non-solicitation covenants for a period of at least one year and a perpetual confidentiality covenant. The Company has agreed to reimburse Mr. Foster for the cost of his attorneys&#x2019; fees incurred in the negotiation and drafting of the employment agreement.<br><br>The above summary is qualified in its entirety by the terms and conditions set forth in the employment agreement, a copy of which is attached hereto as Exhibit 99.2. <br>
</FONT>
</P>
<!-- Item END -->
<BR><BR><BR><BR><P ALIGN="LEFT" STYLE="FONT-SIZE: 10PT"></P><!-- PageBreak START -->
<P>
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<A HREF="#DOCUMENT_TOP">
<U>
<B>
<FONT SIZE="2">Top of the Form</FONT>
</B>
</U>
</A>
</DIV>
<!-- PageBreak END --><P ALIGN="CENTER">
<FONT SIZE="2">
	Exhibit&nbsp;Index
</FONT>
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="60%">
<TR VALIGN="BOTTOM">
<TD WIDTH="8%">
	&nbsp;
</TD>
<TD WIDTH="15%">
	&nbsp;
</TD>
<TD WIDTH="77%">
	&nbsp;
</TD>
</TR>

<BR>
<TR VALIGN="BOTTOM">
<TD NOWRAP ALIGN="LEFT">
<FONT SIZE="1">
<B>
	Exhibit No.
</B>
</FONT>
</TD>
<TD>
<FONT SIZE="1">
	&nbsp;
</FONT>
</TD>
<TD NOWRAP ALIGN="LEFT">
<FONT SIZE="1">
<B>
	Description
</B>
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD NOWRAP ALIGN="CENTER">
<HR SIZE="1" NOSHADE>
</TD>
<TD>
<FONT SIZE="1">
	&nbsp;
</FONT>
</TD>
<TD NOWRAP ALIGN="CENTER">
<HR ALIGN="LEFT" SIZE="1" WIDTH="88%" NOSHADE>
</TD>
</TR>





<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" WIDTH="8%" nowrap>
<FONT SIZE="2">
<DIV ALIGN="LEFT">
	99.1
</DIV>
</FONT>
</TD>
<TD WIDTH="15%">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="77%">
<FONT SIZE="2">
<A HREF="exhibit1.htm" >
Press Release of the Company dated February 13, 2018
</A>
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" WIDTH="8%" nowrap>
<FONT SIZE="2">
<DIV ALIGN="LEFT">
	99.2
</DIV>
</FONT>
</TD>
<TD WIDTH="15%">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="77%">
<FONT SIZE="2">
<A HREF="exhibit2.htm" >
Employment Agreement by and between James C. Foster and the Company dated February 12, 2018
</A>
</FONT>
</TD>
</TR></TABLE></CENTER><!-- PageBreak START -->
<P>
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<A HREF="#DOCUMENT_TOP">
<U>
<B>
<FONT SIZE="2">Top of the Form</FONT>
</B>
</U>
</A>
</DIV>
<!-- PageBreak END --><!-- SignatureHeader START -->
<P ALIGN="CENTER">
<FONT SIZE="2">
<B>
	SIGNATURES
</B>
</FONT>
</P>
<P ALIGN="LEFT">
<FONT SIZE="2">
	Pursuant to the requirements of the Securities Exchange Act of 1934, the
	registrant has duly caused this report to be signed on its behalf by the
	undersigned hereunto duly authorized.
</FONT>
</P>
<!-- SignatureHeader END --><!-- Signature START -->
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
<TR VALIGN="BOTTOM">
<TD WIDTH="19%">
	&nbsp;
</TD>
<TD WIDTH="34%">
	&nbsp;
</TD>
<TD WIDTH="3%">
	&nbsp;
</TD>
<TD WIDTH="1%">
	&nbsp;
</TD>
<TD WIDTH="43%">
	&nbsp;
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD COLSPAN="3" VALIGN="TOP" ALIGN="LEFT">
<FONT SIZE="2">
	Charles River Laboratories International, Inc.
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
<I>
	February 13, 2018
</I>
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
<I>
	By:
</I>
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
<I>
	Matthew Daniel
</I>
<BR>
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<HR SIZE="1" NOSHADE>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
<I>
	Name: Matthew Daniel
</I>
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
<I>
	Title: Corporate Senior Vice President & Deputy General Counsel
</I>
</FONT>
</TD>
</TR>
</TABLE>
</CENTER>
<!-- Signature END --><!-- PageBreak START -->
<P>
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<A HREF="#DOCUMENT_TOP">
<U>
<B>
<FONT SIZE="2">Top of the Form</FONT>
</B>
</U>
</A>
</DIV>
<!-- PageBreak END --><!-- HTMLFooter START -->
</BODY>
</HTML>
<!-- HTMLFooter END -->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
<TITLE ID="1"> EX-99.1 </TITLE>
</HEAD>
<BODY TEXT="#000000" BGCOLOR="#FFFFFF" ALINK="#0000FF" HLINK="#FF0000" VLINK="#800080">

<BODY style="font-family: 'Times New Roman',Times,serif">


<P align="left" style="font-size: 10pt"><FONT style="font-size: 12pt"><img src="e44298-1844437152ebc1eefa_1.jpg">
</FONT>

<P align="left" style="font-size: 12pt"><B>NEWS RELEASE</B>


<P align="center" style="font-size: 12pt"><B>CHARLES RIVER LABORATORIES ANNOUNCES<BR>
EXECUTIVE MANAGEMENT APPOINTMENTS<BR>
&#150; Dr.&nbsp;Davide Molho Appointed to President and Chief Operating Officer &#150;<BR>
&#150; Birgit Girshick Appointed to Corporate Executive Vice President,<BR>
Discovery and Safety Assessment &#150;</B>



<P align="left" style="font-size: 12pt"><B>WILMINGTON, MA, February&nbsp;13, 2018 </B>&#150; Charles River Laboratories International, Inc. (NYSE: CRL)
today announced two new executive management appointments.


<P align="left" style="font-size: 12pt">Dr.&nbsp;Davide Molho, Corporate Executive Vice President and President, Global Research Models &
Services, Safety Assessment and Biologics, will become President and Chief Operating Officer of
Charles River, effective immediately, and will add Discovery Services to his responsibilities. Dr.
Molho has a proven track record of outstanding performance, leading many of the company&#146;s
businesses through important strategic initiatives during his nearly 20&nbsp;years with Charles River.
His extensive operations management experience in both the United States and Europe uniquely
qualifies Dr.&nbsp;Molho to oversee the company&#146;s global organization and provide leadership as Charles
River continues to grow. Dr.&nbsp;Molho will continue to report directly to James C. Foster, Chairman
and Chief Executive Officer.


<P align="left" style="font-size: 12pt">Birgit Girshick, Corporate Senior Vice President, Global Discovery Services, has been appointed
Corporate Executive Vice President, Discovery and Safety Assessment. During her more than 25&nbsp;years
with the Company, Ms.&nbsp;Girshick has established an exceptional record of operational management,
most recently leading the global Discovery business after successfully executing the WIL Research
integration. Realigning management of the Discovery and Safety Assessment businesses under Ms.
Girshick&#146;s leadership will enable Charles River to better leverage the synergies between the two
related units and enhance the extensive services provided to clients. Ms.&nbsp;Girshick will report
directly to Dr.&nbsp;Molho.


<P align="left" style="font-size: 12pt">James C. Foster, Chairman and Chief Executive Officer commented, &#147;I look forward to continuing to
work side-by-side with Dr.&nbsp;Molho and Ms.&nbsp;Girshick as we drive Charles River&#146;s growth and
development over the coming years. We plan to nearly double in size over the course of our
five-year plan, generating significant earnings growth and delivering value to all our
stakeholders, and today&#146;s appointments of Dr.&nbsp;Molho and Ms.&nbsp;Girshick give us the right leadership
structure to support and advance that plan.&#148;


<P align="left" style="font-size: 12pt"><U><B>Management Biographies</B></U>


<P align="left" style="font-size: 12pt">Dr.&nbsp;Davide Molho joined Charles River in our Italian operations in 1999 and was promoted to
Director of Operations for Research Models and Services (RMS)&nbsp;Italy in 2002. In 2005, his role was
expanded to include French RMS operations and in 2007, he became Corporate Vice President, European
Research Models and Services, with responsibility for all European RMS operations. In July&nbsp;2009,
Dr.&nbsp;Molho was promoted to Corporate Senior Vice President, North American & European Research
Models and Services, and was promoted to Corporate Executive Vice President and President, Global
Research Models and Services in December&nbsp;2010. Dr.&nbsp;Molho subsequently assumed the role of
Corporate Executive Vice President and President, North American Operations in October&nbsp;2011 and
then Corporate Executive Vice President and President, Global Research Models & Services, Safety
Assessment and Biologics in December&nbsp;2013. In this role, Dr.&nbsp;Molho was responsible for the global
oversight of these businesses and transitioning to a more fully integrated, global organizational
structure across North America, Europe, and Asia.


<P align="left" style="font-size: 12pt">Dr.&nbsp;Molho received both his D.V. M. degree and his Post Degree in Laboratory Animal Science &
Medicine from University of Milan.


<P align="left" style="font-size: 12pt">Birgit Girshick joined Charles River in 1989 and held positions of increasing responsibility in the
Company&#146;s RMS Germany and RMS Avian Vaccine Services businesses. In 2004, Ms.&nbsp;Girshick was
promoted to General Manager of the RMS Avian Vaccine Services business. She was named Executive
Director, RMS Process Improvement in 2009, and Corporate Vice President, Global Biopharmaceutical
Services in 2010. In 2013, Ms.&nbsp;Girshick was promoted to Corporate Senior Vice President, Research
Models and Biologics Testing Solutions. In this role, she was responsible for identifying growth
opportunities and managing operations for the North American Research Models and Global Biologics
businesses. In 2014, Ms.&nbsp;Girshick was tasked with leading the integration of WIL Research into the
Company&#146;s Safety Assessment business. Having successfully completed the integration, in 2015, Ms.
Girshick assumed the role of Corporate Senior Vice President, Global Discovery Services. In this
role, Ms.&nbsp;Girshick was responsible for transitioning the discovery business units to a global,
integrated organization. As Corporate Executive Vice President, she becomes a member of the
company&#146;s Executive Committee.


<P align="left" style="font-size: 12pt">Ms.&nbsp;Girshick received an M.B.A. degree from the University of Rhode Island and a B.A. degree from
Eastern Connecticut State University.


<P align="left" style="font-size: 12pt"><U><B>Caution Concerning Forward-Looking Statements</B></U>


<P align="left" style="font-size: 12pt">This news release includes forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words
such as &#147;anticipate,&#148; &#147;believe,&#148; &#147;expect,&#148; &#147;will,&#148; &#147;may,&#148; &#147;estimate,&#148; &#147;plan,&#148; &#147;outlook,&#148; and
&#147;project&#148; and other similar expressions that predict or indicate future events or trends or that
are not statements of historical matters. Forward-looking statements include statements in this
news release regarding Charles River&#146;s projected future performance, including revenue and earnings
per share growth. Forward-looking statements are based on Charles River&#146;s current expectations and
beliefs, and involve a number of risks and uncertainties that are difficult to predict and that
could cause actual results to differ materially from those stated or implied by the forward-looking
statements. A further description of these risks, uncertainties, and other matters can be found in
the Risk Factors detailed in Charles River&#146;s Annual Report on Form 10-K as filed on February&nbsp;14,
2017, as well as other filings we make with the Securities and Exchange Commission. Because
forward-looking statements involve risks and uncertainties, actual results and events may differ
materially from results and events currently expected by Charles River, and Charles River assumes
no obligation and expressly disclaims any duty to update information contained in this news release
except as required by law.


<P align="left" style="font-size: 12pt"><B>About Charles River</B>


<P align="left" style="font-size: 12pt">Charles River provides essential products and services to help pharmaceutical and biotechnology
companies, government agencies and leading academic institutions around the globe accelerate their
research and drug development efforts.&nbsp; Our dedicated employees are focused on providing clients
with exactly what they need to improve and expedite the discovery, early-stage development and safe
manufacture of new therapies for the patients who need them. To learn more about our unique
portfolio and breadth of services, visit <U>www.criver.com</U>.


<P align="center" style="font-size: 12pt"># # #


<DIV align="center">
<TABLE style="font-size: 12pt" cellspacing="0" border="0" cellpadding="0" width="95%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="53%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="42%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="font-size: 12pt">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Investor Contact:
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Media Contact:</TD>
</TR>
<TR valign="bottom" style="font-size: 12pt">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Susan E. Hardy
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amy Cianciaruso</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="left" style="font-size: 12pt">Corporate Vice President, Investor Relations Corporate Vice President, Public Relations

<DIV align="center">
<TABLE style="font-size: 12pt" cellspacing="0" border="0" cellpadding="0" width="95%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="45%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="50%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="font-size: 12pt">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">781.222.6190<BR>
susan.hardy@crl.com
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">781.222.6168<BR>
amy.cianciaruso@crl.com</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top" style="border-top: 1px solid #000000"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt; display: none">




<!-- v.121908 -->
</BODY>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit2.htm
<DESCRIPTION>EX-99.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
<TITLE ID="2"> EX-99.2 </TITLE>
</HEAD>
<BODY TEXT="#000000" BGCOLOR="#FFFFFF" ALINK="#0000FF" HLINK="#FF0000" VLINK="#800080">

<BODY style="font-family: 'Times New Roman',Times,serif">


<P align="center" style="font-size: 10pt"><FONT style="font-size: 12pt"><B>CHARLES RIVER LABORATORIES INTERNATIONAL, INC.<BR>
EMPLOYMENT AGREEMENT</B></FONT>



<P align="left" style="font-size: 12pt; text-indent: 4%">THIS EMPLOYMENT AGREEMENT (the &#147;<U>Agreement</U>&#148;) is hereby entered into as of February&nbsp;12,
2018 by and between Charles River Laboratories International, Inc., a Delaware corporation (the
&#147;<U>Company</U>&#148;), and James C. Foster, an individual (the &#147;<U>Executive</U>&#148;) (hereinafter
collectively referred to as &#147;<U>the parties</U>&#148;).


<P align="center" style="font-size: 12pt"><U>RECITALS</U>



<P align="left" style="font-size: 12pt; text-indent: 4%">WHEREAS, the Company currently employs Executive as the Chairman, President and Chief
Executive Officer of the Company;


<P align="left" style="font-size: 12pt; text-indent: 4%">WHEREAS, the Company desires to continue to employ Executive for the period provided in this
Agreement, and Executive desires to accept such continued employment with the Company, subject to
the terms and conditions set forth herein; and


<P align="left" style="font-size: 12pt; text-indent: 4%">WHEREAS, the Company and Executive each desire to memorialize Executive&#146;s employment under
such terms and conditions;


<P align="left" style="font-size: 12pt; text-indent: 4%">NOW, THEREFORE, in consideration of the respective agreements of the parties contained herein,
it is agreed as follows:


<P align="left" style="font-size: 12pt; text-indent: 4%">1.&nbsp;<U>Term</U>. The employment term (the &#147;<U>Employment Term</U>&#148;) of Executive&#146;s
employment under this Agreement shall be for the period commencing on February&nbsp;12, 2018 (the
&#147;<U>Effective Date</U>&#148;) and ending on the fifth (5th) anniversary of the Effective Date, subject
to earlier termination pursuant to <U>Section&nbsp;7</U> hereof. Thereafter, the Employment Term may
be extended by the parties&#146; mutual agreement and with an affirmative vote of a majority of the
independent members of the Board of Directors of the Company (the &#147;<U>Board</U>&#148;) for a specified
consecutive period (an &#147;<U>Extended Term</U>&#148;). For any subsequent extension(s) of the Employment
Term after the Extended Term, the same affirmative vote of a majority of the independent members of
the Board shall be required.


<P align="left" style="font-size: 12pt; text-indent: 4%">2.&nbsp;<U>Employment</U>. During the Employment Term:


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Executive shall be employed as the Chairman and Chief Executive
Officer of the Company. Executive shall report directly and solely to the
Board. Executive shall perform the duties, undertake the responsibilities and
exercise the authority customarily performed, undertaken and exercised by
persons situated in similar executive capacities.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Excluding periods of vacation and sick leave to which Executive
is entitled and other service outside of the Company contemplated in this
<U>Section&nbsp;2(b)</U>, Executive shall devote his full business time and
attention to the affairs of the Company to discharge the responsibilities of
Executive hereunder. Prior to joining or agreeing to serve on any corporate
boards or committees, Executive shall obtain approval of the Board in light of
potential conflicts of interest with the Company or its direct and indirect
subsidiaries, which approval shall not be unreasonably withheld. Executive may
manage personal and family investments, participate in industry organizations,
deliver lectures at educational institutions and serve on charitable boards so
long as such activities do not interfere with the performance of Executive&#146;s
responsibilities hereunder. It is understood that, during Executive&#146;s
employment by the Company, Executive shall not engage in any activities that
constitute a conflict of interest under the Company&#146;s policies.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Executive shall be subject to and shall abide by each of the
personnel policies applicable to senior executives, including but not limited
to, any policy restricting pledging and hedging investments in Company equity
by Company executives, any policy the Company adopts regarding the recovery of
incentive compensation (sometimes referred to as &#147;<U>clawback</U>&#148;) and any
additional clawback provisions as required by law and applicable listing rules.
This <U>Section&nbsp;2(c)</U>, as it specifically applies to such clawback
policies and provisions, shall survive the termination of the Employment Term.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Subject to <U>Sections&nbsp;1</U>, <U>7</U> and <U>8</U> hereof,
(i)&nbsp;Executive has the option to terminate his employment at any time, with or
without advance notice, (ii)&nbsp;prior to the third (3rd) anniversary of the
Effective Date, the Company may only terminate the Executive&#146;s employment for
Cause (as defined below), and may not terminate the Executive&#146;s employment for
any other, or no, reason and (iii)&nbsp;upon or after the third (3rd) anniversary of
the Effective Date, the Company has the option to terminate the Executive&#146;s
employment at any time, with or without advance notice, and with or without
Cause.</TD>
</TR>

</TABLE>


<P align="left" style="font-size: 12pt; text-indent: 4%">3.&nbsp;<U>Annual Compensation</U>.


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Base Salary</U>. During the Employment Term, Executive
shall be paid a base salary of not less than One Million Two Hundred Thirty
Seven Thousand Dollars ($1,237,000) per year, commencing in April, 2018,
subject to review each calendar year. The Executive&#146;s base salary shall not be
decreased and, consistent with past practices, may be increased at the
discretion of the Compensation Committee of the Board (the &#147;<U>Committee</U>&#148;)
on each anniversary of the Effective Date. The Executive&#146;s highest base salary
in effect from time to time will be referred to herein as the &#147;<U>Base
Salary</U>&#148;. The Base Salary shall be paid in equal bi-weekly installments.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Performance Bonus</U>. Subject to the terms of the
Executive Incentive Compensation Program of Charles River Laboratories, Inc.,
effective as of January&nbsp;1, 2016 (as it may be modified or amended, the
&#147;<U>EICP</U>&#148;), for each fiscal year of the Company ending during the
Employment Term (commencing with the 2018 fiscal year), Executive shall be
eligible to receive a target annual cash bonus of 100% of Base Salary (such
target bonus, as may hereafter be increased, the &#147;<U>Target Bonus</U>&#148;),
payable in accordance with the then-current terms of the EICP and the Company&#146;s
customary practices applicable to bonuses paid to Company executives. In no
event shall the terms of any future EICP be less favorable to the Executive
than the EICP in effect as of January&nbsp;1, 2016 unless any such change in terms
is broadly applicable to all officer-level participants.</TD>
</TR>

</TABLE>


<P align="left" style="font-size: 12pt; text-indent: 4%">4.&nbsp;<U>Equity Compensation</U>.


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Outstanding Equity Awards</U>. As of the Effective Date,
Executive holds certain outstanding performance share units (&#147;<U>PSUs</U>&#148;),
stock options, restricted stock grants or restricted stock units
(&#147;<U>RSUs</U>&#148;) in the Company (collectively, the &#147;<U>Outstanding Equity
Awards</U>&#148;). The Company and Executive hereby agree that the vesting schedule
(including, as applicable, the treatment of the Outstanding Equity Awards upon
a &#147;<U>Full Career Retirement</U>&#148; (as such term is defined in the applicable
award agreement)) and all other terms of the Outstanding Equity Awards held by
Executive will remain in full force and effect without modification or
amendment.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Prospective Equity Awards</U>. On or after the Effective
Date, the Company will grant Executive PSUs, stock options, restricted stock
grants, RSUs or other equity awards (collectively, the &#147;<U>Prospective Equity
Awards</U>&#148;) in a manner consistent with the Company&#146;s past practices in making
such grants to the Executive, but in no event will such grants be materially
reduced, subject only to (i)&nbsp;the Compensation Committee of the Board of
Directors exercising its fiduciary duties with respect to evaluating the
Executive&#146;s performance and (ii)&nbsp;the latitude afforded to the Company in
<U>Section&nbsp;7(g)</U> below.</TD>
</TR>

</TABLE>


<P align="left" style="font-size: 12pt; text-indent: 4%">5.&nbsp;<U>Stock Ownership Guidelines</U>. Executive agrees to comply with any stock ownership
guidelines adopted by the Company applicable to Executive.


<P align="left" style="font-size: 12pt; text-indent: 4%">6.&nbsp;<U>Other Benefits</U>. During the Employment Term:


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Employee Benefits</U>. Executive shall be entitled to
participate in all employee benefit plans, practices and programs maintained by
the Company and made available to employees generally. Executive&#146;s
participation in such plans, practices and programs shall be on the same basis
and terms as are applicable to other senior executives of the Company or, in
the case of any enhanced benefits specifically reserved for the Chairman and
Chief Executive Officer of the Company, in a manner consistent with past
practices.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Business Expenses/Attorney&#146;s Fees</U>. Upon submission of
proper invoices in accordance with, and subject to, the Company&#146;s normal
policies and procedures, the Company shall promptly reimburse the Executive for
all reasonable out-of-pocket business, entertainment and travel expenses
incurred by him in connection with the performance of his duties hereunder.
The Company further agrees to pay all attorneys&#146; fees incurred by the Executive
in connection with the negotiation and drafting of the Agreement.</TD>
</TR>

</TABLE>


<P align="left" style="font-size: 12pt; text-indent: 4%">7.&nbsp;<U>Termination and Compensation Upon Termination</U>. Executive&#146;s employment with the
Company hereunder may be terminated under the circumstances set forth below and, upon each such
specified termination, Executive shall be entitled to the benefits enumerated below;
<U>provided</U>, <U>however</U>, that, notwithstanding anything contained herein to the contrary,
to the extent required by Section&nbsp;409A (&#147;<U>Section&nbsp;409A</U>&#148;) of the Internal Revenue Code of
1986, as amended (the &#147;<U>Code</U>&#148;), Executive shall not be considered to have terminated
employment with the Company for purposes of this Agreement until he would be considered to have
incurred a &#147;separation from service&#148; from the Company within the meaning of Section&nbsp;409A.


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Disability or Death</U>. The Company may terminate
Executive&#146;s employment on written notice to Executive after having established
Executive&#146;s Disability (as defined below) or Executive&#146;s employment shall be
terminated as of the date of Executive&#146;s death. For purposes of this
Agreement, &#147;<U>Disability</U>&#148; shall have the meaning as set forth in that
certain Amended and Restated Change in Control Agreement dated as of February
8, 2006 and subsequently amended on December&nbsp;15, 2008, between the Company and
Executive (the &#147;<U>Change in Control Agreement</U>&#148;). In establishing the
existence of a Disability under this <U>Section&nbsp;7(a)</U>, the Company shall
rely upon the written opinion of the physician regularly attending Executive in
determining whether a Disability is deemed to exist. If the Company disagrees
with the opinion of such physician, the Company may choose a second physician,
and, in turn, the two (2)&nbsp;physicians shall choose a third physician. The
written opinion of a majority of the three (3)&nbsp;physicians shall be conclusive
as to Executive&#146;s Disability. The expenses associated with the utilization of
any physician other than the physician regularly attending Executive shall be
borne solely by the Company. Executive hereby consents to any required medical
examination and agrees to furnish any medical information requested by the
Company and to waive any applicable physician/patient privilege that may arise
because of such determination. Unless and until the Executive&#146;s Disability has
been established by the Company, the Executive will remain entitled to receive
and accrue all compensation provided in <U>Sections&nbsp;3</U> and <U>4</U> above.
In the event that the Executive&#146;s employment is terminated because the Company
establishes the Executive&#146;s Disability or in the event of Executive&#146;s death,
Executive or Executive&#146;s beneficiaries shall be entitled to the benefits
provided in this <U>Section&nbsp;7(a)</U>.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(1)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company shall pay or deliver to Executive
(or his beneficiaries, as applicable) any &#147;<U>Accrued
Compensation</U>&#148;, meaning the items in clauses (i)&nbsp;through (iv)&nbsp;below,
collectively:</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(i)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>reimbursement for reasonable and
necessary expenses incurred by Executive on behalf of the
Company for the period ending on the termination date in
accordance with the Company&#146;s then current policy governing
reimbursement of expenses;</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(ii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>any previous compensation which
Executive has previously deferred (including any interest earned
or credited thereon), in accordance with the terms and
conditions of the applicable deferred compensation plans or
arrangements then in effect;</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(iii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>equity and incentive awards, to
the extent previously vested, with such payment and delivery in
accordance with the terms of such awards; and</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(iv)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>any amount or benefit as provided
under any benefit plan or program, including, without
limitation, the then current EICP at the time such benefit would
be paid and delivered to similarly situated officers of the
Company;</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(2)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company shall pay to Executive (or his
beneficiaries, as applicable) within sixty (60)&nbsp;days following the
termination date, any bonus earned but unpaid in respect of any fiscal
year preceding the termination date, without requirement that Executive
be employed on the date that such bonus would otherwise have been paid;
and</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(3)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Each unvested equity award held by Executive at
the time of termination shall be governed by the terms of the
applicable award agreement.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Cause</U>. &#147;<U>Cause</U>&#148; shall have the same meaning as
set forth in Section&nbsp;16.3 of the Change in Control Agreement, <U>provided</U>,
<U>however</U>, that in the case of any events described in Section&nbsp;16.3(a),
16.3(b), or 16.3(d) of the Change in Control Agreement, such event shall not
constitute &#147;Cause&#148; for termination hereunder unless and until (i)&nbsp;the Company
provides a written notice to the Executive which sets forth in specific detail
the basis for the Company&#146;s belief that Executive&#146;s conduct provides grounds
for a termination for Cause, and (ii)&nbsp;such conduct, to the extent curable, is
not cured by the Executive, as reasonably determined by the Company, within
thirty (30)&nbsp;days after receipt of such written notice. If the Executive fails
or is unable to cure as described in the preceding sentence, or in the event
that Cause exists under Section&nbsp;16.3(c) of the Change in Control Agreement, the
Company, with an affirmative vote of a majority of the independent members of
the Board, may terminate the Executive&#146;s employment for Cause effective as of
the date of the Notice of Termination (as defined in <U>Section&nbsp;8</U> hereof).
For the avoidance of doubt, a termination for Cause as provided herein may
occur before or after the occurrence of a &#147;<U>Change in Control</U>&#148; (as
defined in the Change in Control Agreement). If Executive&#146;s employment is
terminated by the Company for Cause, then the Company shall pay Executive (or
his beneficiaries, as applicable) any Accrued Compensation; <U>provided</U>
that Executive shall forfeit all vested and unexercised Outstanding Equity
Awards and Prospective Equity Awards.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Voluntary Termination by the Executive</U>. The Executive
may voluntarily terminate his employment.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(1)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Prior to the third (3rd) anniversary of the
Effective Date, Executive may voluntarily terminate his employment by
delivering to the Company a Notice of Termination not less than one
hundred eighty (180)&nbsp;days prior to the termination of Executive&#146;s
employment and the Company shall have the option to exercise the Garden
Leave Election (as defined below) prior to the expiration of such one
hundred eighty (180)&nbsp;day notice period. The &#147;<U>Garden Leave
Election</U>&#148; means the Company&#146;s election to suspend Executive&#146;s
active duties and responsibilities prior to the expiration of the
applicable notice period; <U>provided</U> that, if the Company
exercises the Garden Leave Election at the beginning of or at any time
during such notice period, the Company shall provide written notice to
the Executive. For the avoidance of doubt, the Company&#146;s exercise of
the Garden Leave Election shall not terminate the Executive&#146;s
employment with the Company. If Executive&#146;s employment is terminated
by Executive prior to the third (3rd) anniversary of the Effective Date
and such termination is not in connection with a Change in Control,
then, subject to <U>Section&nbsp;15(e)</U>, Executive shall be entitled to
the benefits provided in this <U>Section&nbsp;7(c)(1)</U>.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(i)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company shall pay to
Executive any Accrued Compensation;</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(ii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If Executive remains actively
employed with the Company during such one hundred eighty (180)
day notice period, the Company shall continue to pay to
Executive his full compensation (including, for the avoidance of
doubt, Base Salary, pro-rated bonus eligibility, equity award
eligibility and the continued vesting of any previously-granted
equity awards) during such period of active employment; and</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(iii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If the Company exercises the
Garden Leave Election during such one hundred eighty (180)&nbsp;day
notice period, then, after such exercise, the Company shall
continue to pay to Executive his Base Salary (payable in
accordance with the Company&#146;s regular payroll practices as in
effect at the time of such Garden Leave Election) and the
Executive shall be entitled to continued vesting of any
previously-granted equity awards for the balance of such one
hundred eighty (180)&nbsp;day notice period. For the avoidance of
doubt, in no event will the Company&#146;s exercise of the Garden
Leave Election impair Executive&#146;s entitlement to receive any
bonus earned prior to such exercise, even if payment of such
bonus would not occur until after such exercise.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(2)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Upon or after the third (3rd) anniversary of
the Effective Date, Executive may voluntarily terminate his employment
by delivering to the Company a Notice of Termination not less than
twelve (12)&nbsp;months prior to the termination of Executive&#146;s employment
and the Company shall have the option to exercise the Garden Leave
Election prior to the expiration of such twelve (12)&nbsp;month notice
period. If Executive&#146;s employment is terminated by Executive upon or
after the third (3rd) anniversary of the Effective Date and such
termination is not in connection with a Change in Control, then,
subject to <U>Section&nbsp;15(e)</U>, Executive shall be entitled to the
benefits provided in this <U>Section&nbsp;7(c)(2)</U>.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(i)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company shall pay to
Executive any Accrued Compensation;</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(ii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If Executive remains actively
employed with the Company during such twelve (12)&nbsp;month notice
period, the Company shall continue to pay to Executive his full
compensation (including, for the avoidance of doubt, Base
Salary, pro-rated bonus eligibility, equity award eligibility
and the continued vesting of any previously-granted equity
awards) during such period of active employment;</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(iii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If the Company exercises the
Garden Leave Election during such twelve (12)&nbsp;month notice
period, then, after such exercise, the Company shall continue to
pay to Executive his Base Salary (payable in accordance with the
Company&#146;s regular payroll practices as in effect at the time of
such Garden Leave Election) and the Executive shall be entitled
to continued vesting of any previously-granted equity awards for
the balance of such twelve (12)&nbsp;month notice period. For the
avoidance of doubt, in no event will the Company&#146;s exercise of
the Garden Leave Election impair Executive&#146;s entitlement to
receive any bonus earned prior to such exercise, even if payment
of such bonus would not occur until after such exercise; and</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(iv)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Notwithstanding anything to the
contrary in the applicable award agreements for Prospective
Equity Awards, Executive&#146;s Prospective Equity Awards shall
continue to be outstanding, fully vest, and become exercisable
after his termination of employment in the same manner as if his
employment with the Company had continued.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Without Cause</U>. The Company may terminate Executive&#146;s
employment without Cause only upon or after the third (3rd) anniversary of the
Effective Date, and only upon an affirmative vote of a majority of the
independent members of the Board, in which event the Executive shall be
entitled to the benefits provided in <U>Section&nbsp;7(d)(1)</U> as follows.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(1)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company may deliver to Executive a Notice
of Termination not less than twelve (12)&nbsp;months prior to the
termination of Executive&#146;s employment without Cause and the Company
shall have the option to exercise the Garden Leave Election prior to
the expiration of such twelve (12)&nbsp;month notice period. If, upon or
after the third (3rd) anniversary of the Effective Date, the Company
provides to Executive a Notice of Termination not less than twelve (12)
months prior to the termination of Executive&#146;s employment and such
termination is not in connection with a Change in Control, then,
subject to <U>Section&nbsp;15(e)</U> hereof and the conditions of the 2010
Charles River Corporate Officer Separation Plan, last revised on April
30, 2010 (as it may be revised or amended, the &#147;<U>Corporate Officer
Separation Plan</U>&#148;) or any successor plan, Executive shall be
entitled to the benefits provided in this <U>Section&nbsp;7(d)(1)</U>. In
no event shall the terms of any revised or amended Corporate Officer
Separation Plan be less favorable to the Executive than the Corporate
Officer Separation Plan in effect as of April&nbsp;30, 2010 unless any such
changes in terms are broadly applicable to all officer-level
participants.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(i)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company shall pay to
Executive any Accrued Compensation;</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(ii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If Executive remains actively
employed with the Company during such twelve (12)&nbsp;month notice
period, the Company shall continue to pay to Executive his full
compensation (including, for the avoidance of doubt, Base
Salary, pro-rated bonus eligibility, equity award eligibility
and the continued vesting of any previously-granted equity
awards) during such period of active employment;</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(iii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If the Company exercises the
Garden Leave Election during the twelve (12)&nbsp;month notice
period, then, after such exercise, the Company shall continue to
pay to the Executive his Base Salary (payable in accordance with
the Company&#146;s regular payroll practices as in effect at the time
of such Garden Leave Election) and the Executive shall be
entitled to continued vesting of any previously-granted equity
awards for the balance of such twelve (12)&nbsp;month notice period.
For the avoidance of doubt, in no event will the Company&#146;s
exercise of the Garden Leave Election impair Executive&#146;s
entitlement to receive any bonus earned prior to such exercise,
even if payment of such bonus would not occur until after such
exercise;</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(iv)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company shall pay to
Executive the maximum severance pay and benefits allowable under
the Corporate Officer Separation Plan or any successor plan as
though all conditions for any such payment and benefit described
therein had been satisfied (noting that the condition expressly
imposed in Section&nbsp;9.1 of such plan will be satisfied by
adherence to the requirements of <U>Section&nbsp;12</U> hereof), and
further provided that such severance pay will be no less than
continued payment of Executive&#146;s Base Salary for a period of two
(2)&nbsp;years; and</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(v)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Notwithstanding anything to the
contrary in the applicable award agreements for Prospective
Equity Awards, Executive&#146;s Prospective Equity Awards shall
continue to be outstanding, fully vest, and become exercisable
after his termination of employment in the same manner as if his
employment with the Company had continued.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(e)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Expiration of the Employment Term Upon Non-Renewal</U>.
Unless the Company and Executive agree to an alternative relationship,
Executive&#146;s employment shall terminate upon the expiration of the Employment
Term and, subject to <U>Section&nbsp;15(e)</U> hereof, Executive shall be entitled
to the benefits provided in this <U>Section&nbsp;7(e)</U>.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(i)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Company shall pay to
Executive any Accrued Compensation;</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(ii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Notwithstanding anything to the
contrary in the applicable award agreements for Prospective
Equity Awards, Executive&#146;s Prospective Equity Awards shall
continue to be outstanding, fully vest, and become exercisable
after his termination of employment in the same manner as if his
employment with the Company had continued; and</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="15%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(iii)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>For the avoidance of doubt,
Executive shall have no further entitlement to any severance or
other payments under the Corporate Officer Separation Plan or
any successor plan.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(f)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Change in Control</U>. If Executive&#146;s employment is
terminated in connection with a Change in Control (as such term is defined in
the Change in Control Agreement), Executive shall be entitled to the benefits
provided in the Change in Control Agreement. For the avoidance of doubt,
Executive shall not be entitled to any payments or benefits under <U>Sections
7(a)</U> through <U>7(e)</U>.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(g)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Latitude of the Committee</U>. Notwithstanding anything to
the contrary contained in this <U>Section&nbsp;7</U>, after a Notice of Termination
is delivered by the Executive, to the extent that Executive continues to
actively perform his duties or the Company exercises the Garden Leave Election
during the applicable notice period, the Committee shall have the authority to
depart from past practices in determining whether to grant Executive an equity
award during such notice period (or take other action), and, if it should elect
to grant such an award, the Committee shall have the authority to determine the
amount of the award in its full discretion.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(h)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>No Offset &#150; No Mitigation</U>. Notwithstanding anything to
the contrary contained herein or in the Corporate Officer Separation Plan or
any successor plan, Executive shall not be required to mitigate the amount of
any payment provided for under this <U>Section&nbsp;7</U> by seeking other
employment or otherwise and no such payment shall be offset or reduced by the
amount of any compensation or benefits provided to Executive in any subsequent
employment.</TD>
</TR>

</TABLE>


<P align="left" style="font-size: 12pt; text-indent: 4%">8.&nbsp;<U>Notice of Termination</U>. Any purported termination by the Company or by Executive
shall be communicated by written Notice of Termination to the other party hereto. For purposes of
this Agreement, a &#147;<U>Notice of Termination</U>&#148; shall mean a notice delivered to Executive or the
General Counsel of the Company, as applicable, which indicates a termination date and the specific
termination provision in this Agreement relied upon and sets forth in reasonable detail the facts
and circumstances claimed to provide a basis for termination of Executive&#146;s employment under the
provision so indicated. For purposes of this Agreement, no such purported termination of
Executive&#146;s employment hereunder shall be effective without such Notice of Termination (unless
waived by the party entitled to receive such notice).


<P align="left" style="font-size: 12pt; text-indent: 4%">9.&nbsp;<U>Section&nbsp;409A</U>. The Company and the Executive intend for the payments and benefits
under this Agreement to be exempt from Section&nbsp;409A of the Code or, if not so exempt, to be paid or
provided in a manner which complies with the requirements of such section, and intend that this
Agreement shall be construed and administered in accordance with such intention. If any payments
or benefits due to Executive hereunder would cause the application of an accelerated or additional
tax under Section&nbsp;409A, such payments or benefits shall be restructured in a mutually agreed upon
manner that, to the extent possible, preserves the economic benefit and original intent thereof but
does not cause such an accelerated or additional tax. For purposes of the limitations on
nonqualified deferred compensation under Section&nbsp;409A, each payment of compensation under this
Agreement shall be treated as a separate payment of compensation. Without limiting the foregoing
and notwithstanding anything contained herein to the contrary, to the extent required in order to
avoid accelerated taxation and/or tax penalties under Section&nbsp;409A, amounts that would otherwise be
payable and benefits that would otherwise be provided pursuant to this Agreement during the
six-month period immediately following Executive&#146;s separation from service shall instead be paid on
the first business day after the date that is six months following Executive&#146;s termination date (or
death, if earlier). Notwithstanding anything to the contrary in this Agreement, all (A)
reimbursements and (B)&nbsp;in-kind benefits provided under this Agreement shall be made or provided in
accordance with the requirements of Section&nbsp;409A, including, where applicable, the requirement that
(x)&nbsp;the amount of expenses eligible for reimbursement, or in-kind benefits provided, during a
calendar year may not affect the expenses eligible for reimbursement, or in-kind benefits to be
provided, in any other calendar year; (y)&nbsp;the reimbursement of an eligible expense will be made no
later than the last day of the calendar year following the year in which the expense is incurred;
and (z)&nbsp;the right to reimbursement or in-kind benefits is not subject to liquidation or exchange
for another benefit.


<P align="left" style="font-size: 12pt; text-indent: 4%">10.&nbsp;<U>Employee Protection</U>. Nothing in this Agreement or otherwise limits Executive&#146;s
ability to communicate directly with and provide information, including documents, not otherwise
protected from disclosure by any applicable law or privilege to the Securities and Exchange
Commission (the &#147;<U>SEC</U>&#148;) or any other federal, state or local governmental agency or
commission (&#147;<U>Government Agency</U>&#148;) regarding possible legal violations, without disclosure to
the Company. The Company may not retaliate against Executive for any of these activities, and
nothing in this Agreement or otherwise requires Executive to waive any monetary award or other
payment that Executive might become entitled to from the SEC or any other Government Agency.


<P align="left" style="font-size: 12pt; text-indent: 4%">11.&nbsp;<U>Records and Confidential Data.</U>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Executive acknowledges that in connection with the performance
of his duties during the Employment Term, the Company will make available to
Executive, or Executive will have access to, certain Confidential Information
(as defined below) of the Company and its affiliates. Executive acknowledges
and agrees that any and all Confidential Information disclosed to, or learned
or obtained by, Executive during the course of his employment by the Company or
otherwise, whether developed by Executive alone or in conjunction with others
or otherwise, shall be and is the sole and exclusive property of the Company
and its affiliates and Executive hereby assigns to the Company any and all
right, title and interest Executive may have or acquire in and to such
Confidential Information.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Subject to <U>Section&nbsp;10</U> hereof, the Confidential
Information will be kept confidential by Executive, will not be used in any
manner which is detrimental to the Company, will not be used other than in
connection with Executive&#146;s discharge of his duties hereunder, and will be
safeguarded by Executive from unauthorized disclosure. Executive acknowledges
and agrees that the confidentiality restrictions set forth herein shall apply
to any and all Confidential Information disclosed to, or learned or obtained
by, Executive, whether before, on or after the date hereof. For the avoidance
of doubt, nothing in this <U>Section&nbsp;11(b)</U> shall prevent Executive from
complying with a valid legal requirement (whether by oral questions,
interrogatories, requests for information or documents, subpoena, civil
investigative demand or similar process) to disclose any Confidential
Information or from exercising any legally protected whistleblower rights
(including under Rule&nbsp;21F under the Securities Exchange Act of 1934, as
amended).</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Following the termination of Executive&#146;s employment hereunder,
subject to <U>Section&nbsp;10</U> hereof and as soon as possible after the
Company&#146;s written request, Executive will return to the Company all written
Confidential Information which has been provided to Executive and Executive
will (at Company&#146;s expense) return or destroy (or cooperate with any reasonable
Company requested process to return or destroy) all copies of any analyses,
compilations, studies or other documents prepared by Executive or for
Executive&#146;s use containing or reflecting any Confidential Information. Within
five (5)&nbsp;business days of the receipt of such request by Executive, he shall,
upon written request of the Company, deliver to the Company a document
certifying his compliance with this <U>Section&nbsp;11(c)</U>.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>For the purposes of this Agreement, &#147;<U>Confidential
Information</U>&#148; shall mean all confidential and proprietary information of the
Company and its affiliates, including, without limitation, information derived
from reports, investigations, experiments, research, work in progress,
drawings, designs, plans, proposals, codes, marketing and sales programs,
client lists, client mailing lists, supplier lists, financial projections, cost
summaries, pricing formulas, marketing studies relating to prospective business
opportunities and all other know-how, trade secrets, inventions, concepts,
ideas, materials, or information developed, prepared or performed for or by the
Company or its affiliates. For purposes of this Agreement, the Confidential
Information shall not include and Executive&#146;s obligation&#146;s shall not extend to
information that Executive can demonstrate with competent evidence is
(i)&nbsp;generally available to the public without any action or involvement by
Executive or (ii)&nbsp;independently obtained by Executive from a third party on a
non-confidential and authorized basis. Notwithstanding anything in this
<U>Section&nbsp;11</U> to the contrary, Executive may disclose Confidential
Information to the extent it is required to be disclosed by law or pursuant to
judicial process or administrative subpoena; <U>provided</U> that, subject to
<U>Sections&nbsp;10</U> and <U>11(e)</U> hereof, Executive shall first give
written notice to the Company and reasonably cooperate with the Company to
obtain a protective order or other measures preserving the confidential
treatment of such Confidential Information and requiring that the information
or documents so disclosed be used only for the purposes required by law or
pursuant to judicial process or administrative subpoena.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(e)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pursuant to Section&nbsp;7 of the Defend Trade Secrets Act of 2016
(which added 18 U.S.C. &#167; 1833(b)), the Company and Executive acknowledge and
agree that Executive shall not have criminal or civil liability under any
federal or State trade secret law for the disclosure of a trade secret that (A)
is made (i)&nbsp;in confidence to a federal, state, or local government official,
either directly or indirectly, or to an attorney and (ii)&nbsp;solely for the
purpose of reporting or investigating a suspected violation of law; or (B)&nbsp;is
made in a complaint or other document filed in a lawsuit or other proceeding,
if such filing is made under seal. In addition and without limiting the
preceding sentence, if Executive files a lawsuit for retaliation by the Company
for reporting a suspected violation of law, Executive may disclose the trade
secret to Executive&#146;s attorney and may use the trade secret information in the
court proceeding, if Executive (X)&nbsp;files any document containing the trade
secret under seal and (Y)&nbsp;does not disclose the trade secret, except pursuant
to court order. Nothing in this Agreement or otherwise is intended to conflict
with 18 U.S.C. &#167; 1833(b) or create liability for disclosures of trade secrets
that are expressly allowed by such Section.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(f)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>In connection with Executive&#146;s employment with the Company,
Executive will not use any confidential or proprietary information Executive
may have obtained in connection with employment with his current or any prior
employer.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(g)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Executive&#146;s obligations under this <U>Section&nbsp;11</U> shall
survive the termination of the Employment Term.</TD>
</TR>

</TABLE>


<P align="left" style="font-size: 12pt; text-indent: 4%">12.&nbsp;<U>Restrictive Covenants</U>. In the event that Executive&#146;s employment by the Company
shall be terminated as described in <U>Sections&nbsp;7(c)</U>, <U>7(d)</U> and <U>7(e)</U> hereof,
Executive shall execute a release agreement (as set forth in <U>Section&nbsp;15(e)</U> hereof), which
shall include non-competition and non-solicitation covenants for a period of at least one (1)&nbsp;year,
which release agreement is satisfactory to the Company. Executive&#146;s obligations under such release
shall survive the termination of the Employment Term.


<P align="left" style="font-size: 12pt; text-indent: 4%">13.&nbsp;<U>Remedies for Breach of Obligations under Sections&nbsp;11 or 12 hereof</U>. Executive
acknowledges that the Company may suffer irreparable injury, not readily susceptible of valuation
in monetary damages, if Executive breaches his obligations under <U>Sections&nbsp;11</U> or <U>12</U>
hereof. Accordingly, Executive agrees that the Company will be entitled, in addition to any other
available remedies, to seek injunctive relief against any breach or prospective breach by Executive
of his obligations under <U>Sections&nbsp;11</U> or <U>12</U> hereof. Executive agrees that process
in any or all of those actions or proceedings may be served by registered mail, addressed to the
last address provided by Executive to the Company, or in any other manner authorized by law. This
<U>Section&nbsp;13</U> shall survive the termination of the Employment Term.


<P align="left" style="font-size: 12pt; text-indent: 4%">14.&nbsp;<U>Cooperation</U>.


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>For a period of two (2)&nbsp;years following Executive&#146;s termination
of employment for any reason, subject to <U>Section&nbsp;10</U> hereof, Executive
agrees to make himself reasonably available to cooperate with the Company and
its affiliates in matters that materially concern: (i)&nbsp;requests for information
about the services Executive provided to the Company and its affiliates during
his employment with the Company and its affiliates, (ii)&nbsp;the defense or
prosecution of any claims or actions now in existence or which may be brought
in the future against or on behalf of the Company and its affiliates which
relate to events or occurrences that transpired while Executive was employed by
the Company and its affiliates and as to which Executive has, or would
reasonably be expected to have, personal experience, knowledge or information
or (iii)&nbsp;any investigation or review by any federal, state or local regulatory,
quasi-regulatory or self-governing authority (including, without limitation,
the US Department of Justice, the US Federal Trade Commission or the SEC) as
any such investigation or review relates to events or occurrences that
transpired while Executive was employed by the Company and its affiliates.
Executive&#146;s cooperation shall include: (A)&nbsp;making himself reasonably available
to meet and speak with officers or employees of the Company, the Company&#146;s
counsel or any third-parties at the request of the Company at times and
locations to be mutually agreed by Executive and the Company reasonably and in
good faith, taking into account the Company&#146;s business and Executive&#146;s business
and personal needs (the &#147;<U>Company Cooperation</U>&#148;) and (B)&nbsp;giving accurate
and truthful information at any interviews and accurate and truthful testimony
in any legal proceedings or actions (the &#147;<U>Witness Cooperation</U>&#148;).
Nothing in this <U>Section&nbsp;14(a)</U> shall be construed to limit in any way
any rights Executive may have at applicable law not to provide testimony with
regard to specific matters. Unless required by law or legal process, Executive
will not knowingly or intentionally furnish information to or cooperate with
any non-governmental entity (other than the Company) in connection with any
potential or pending proceeding or legal action involving matters arising
during Executive&#146;s employment with the Company and its affiliates. In
addition, at the request of the Company, Executive shall be required to
complete a directors&#146; and officers&#146; questionnaire to facilitate the Company&#146;s
preparation and filing of its proxy statement and periodic reports with the
SEC.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Executive shall not be entitled to any payments in addition to
those otherwise set forth in this Agreement in respect of any Company
Cooperation or Witness Cooperation, regardless of when provided. The Company
will reimburse Executive for any reasonable, out-of-pocket travel, hotel and
meal expenses incurred in connection with Executive&#146;s performance of
obligations pursuant to this <U>Section&nbsp;14</U> for which Executive has
obtained prior approval from the Company.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Nothing in this Agreement or any other agreement by and between
the parties is intended to or shall preclude or in any way limit or restrict
Executive from providing accurate and truthful testimony or information to any
governmental agency.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>This <U>Section&nbsp;14</U> shall survive the termination of the
Employment Term.</TD>
</TR>

</TABLE>


<P align="left" style="font-size: 12pt; text-indent: 4%">15.&nbsp;<U>Miscellaneous</U>.


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Successors and Assigns</U>.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(1)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>This Agreement shall be binding upon and shall
inure to the benefit of the Company, its successors and permitted
assigns. The Company may not assign or delegate any rights or
obligations hereunder except to a successor (whether direct or
indirect, by purchase, merger, consolidation or otherwise) to all or
substantially all of the business and/or assets of the Company, as
applicable. Except for purposes of determining the occurrence of a
Change in Control, the term &#147;<U>the Company</U>&#148; as used herein shall
mean a corporation or other entity acquiring all or substantially all
the assets and business of the Company, as the case may be, (including
this Agreement) whether by operation of law or otherwise.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(2)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Neither this Agreement nor any right or
interest hereunder shall be assignable or transferable by Executive,
his beneficiaries or legal representatives, except by will or by the
laws of descent and distribution.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(3)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>This Agreement shall inure to the benefit of
and be enforceable by Executive&#146;s legal personal representatives.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Notice</U>. For the purposes of this Agreement, notices
and all other communications provided for in the Agreement (including the
Notice of Termination) shall be in writing and shall be deemed to have been
duly given when personally delivered or sent by Certified mail, return receipt
requested, postage prepaid, addressed to the respective addresses last given by
each party to each other party; <U>provided</U> that all notices to the
Company shall be directed to the attention of the General Counsel of the
Company. All notices and communications shall be deemed to have been received
on the date of delivery thereof or on the third business day after the mailing
thereof, except that notice of change of address shall be effective only upon
receipt.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Indemnity Agreement</U>. The Company agrees to indemnify
and hold Executive harmless to the fullest extent permitted by applicable law
for acts and omissions as an employee, director, or officer of the Company, as
in effect at the time of the subject act or omission, in respect of any and all
actions, suits, proceedings, claims, demands, judgments, costs, expenses
(including reasonable attorney&#146;s fees), losses, and damages resulting from the
Executive&#146;s performance of the Executive&#146;s duties and obligations with the
Company. In connection therewith, Executive shall further be entitled to the
protection of any insurance policies which the Company elects to maintain
generally for the benefit of the Company&#146;s directors and officers, against all
costs, charges and expenses whatsoever incurred or sustained by Executive in
connection with any action, suit or proceeding to which he may be made a party
by reason of his being or having been a director, officer or employee of the
Company. This provision shall survive any termination of the Employment Term.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Withholding</U>. The Company shall be entitled to withhold
the amount, if any, of all taxes of any applicable jurisdiction required to be
withheld by an employer with respect to any amount paid to Executive hereunder.
The Company, in its sole and absolute discretion, shall make all
determinations as to whether it is obligated to withhold any taxes hereunder
and the amount hereof.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(e)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Release of Claims</U>. The termination benefits described
in <U>Sections&nbsp;7(c)</U>, <U>7(d</U>) and <U>7(e</U>) hereof (other than
Accrued Compensation and compensation paid to Executive during active
employment) shall be conditioned on Executive delivering to the Company, and
failing to revoke, a signed release of claims acceptable to the Company within
twenty-one (21)&nbsp;days following Executive&#146;s termination date; <U>provided</U>,
<U>however</U>, that Executive shall not be required to release any vested
benefits under any policy or plan of the Company or any post-employment rights,
compensation or benefits that are expressly provided under this Agreement.
Notwithstanding any provision of this Agreement to the contrary, in no event
shall the timing of Executive&#146;s execution of the release, directly or
indirectly, result in Executive designating the calendar year of payment, and,
to the extent required by Section&nbsp;409A, if a payment that is subject to
execution of the release could be made in more than one taxable year, payment
shall be made in the later taxable year. Where applicable, references to
Executive in this <U>Section&nbsp;15(e)</U> shall refer to Executive&#146;s
representative or estate.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(f)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Modification</U>. No provision of this Agreement may be
modified, waived or discharged unless such waiver, modification or discharge is
agreed to in writing and signed by Executive and by the Company following
authorization by an affirmative vote of a majority of the independent members
of the Board. No waiver by either party hereto at any time of any breach by
the other party hereto of, or compliance with, any condition or provision of
this Agreement to be performed by the other party shall be deemed a waiver of
similar or dissimilar provisions or conditions at the same or at any prior or
subsequent time. No agreement or representations, oral or otherwise, express
or implied, with respect to the subject matter hereof have been made by any
party which are not expressly set forth in this Agreement.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(g)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Arbitration</U>. Any dispute or controversy arising under
or in connection with this Agreement shall be settled exclusively by
arbitration conducted before a single arbitrator in Boston, Massachusetts in
accordance with the commercial rules of the American Arbitration Association
(&#147;<U>AAA</U>&#148;) then in effect. Unless a mutually acceptable arbitrator shall
have been selected by the parties within 30&nbsp;days of the initiation of
arbitration proceedings, then upon application of either party to the Boston
office of the AAA, the AAA shall designate such arbitrator. Judgment may be
entered on the arbitrator&#146;s award in any court having jurisdiction,
<U>provided</U>, <U>however</U>, that Executive shall be entitled to seek
specific performance of his right to be paid until the termination date during
the pendency of any dispute or controversy arising under or in connection with
this Agreement.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(h)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Effect of Other Law</U>. Anything herein to the contrary
notwithstanding, the terms of this Agreement shall be modified to the extent
required to meet the provisions of the Sarbanes-Oxley Act of 2002, Section
409A, the Dodd-Frank Wall Street Reform and Consumer Protection Act or other
law applicable to the employment arrangements between Executive and the
Company. Any delay in providing benefits or payments or any failure to provide
a benefit or payment, which delay results from or failure is required for such
legal compliance, shall not in and of itself constitute a breach of this
Agreement; <U>provided</U>, <U>however</U>, that the Company shall provide
economically equivalent payments or benefits to Executive to the extent
permitted by law as soon as practicable after such benefits or payments are
due. Any request or requirement that Executive repay compensation that is
required under the first sentence of this <U>Section&nbsp;15(h)</U>, or pursuant to
a Company policy that is applicable to other executive officers of the Company
and that is designed to advance the legitimate corporate governance objectives
of the Company, shall not in and of itself constitute a breach of this
Agreement.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(i)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Governing Law</U>. This Agreement shall be governed by and
construed and enforced in accordance with the laws of the Commonwealth of
Massachusetts applicable to contracts executed in and to be performed entirely
within such Commonwealth, without giving effect to the conflict of law
principles thereof.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(j)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>No Conflicts</U>. As a condition to the effectiveness of
this Agreement, Executive represents and warrants to the Company that he is not
a party to or otherwise bound by any agreement or arrangement (including,
without limitation, any license, covenant, or commitment of any nature), or
subject to any judgment, decree, or order of any court or administrative
agency, that would conflict with or will be in conflict with or in any way
preclude, limit or inhibit Executive&#146;s ability to execute this Agreement or to
carry out his duties and responsibilities hereunder. In the event that the
Company determines that Executive&#146;s duties hereunder may conflict with an
agreement or arrangement to which Executive is bound, Executive shall be
required to cease engaging in any such activities, duties or responsibilities
(including providing supervisory services over certain subsets of the Company&#146;s
business operations) and the Company will take steps to restrict Executive&#146;s
access to, and participation in, any such activities.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(k)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Severability</U>. The provisions of this Agreement shall
be deemed severable and the invalidity or unenforceability of any provision
shall not affect the validity or enforceability of the other provisions hereof.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="1%" nowrap align="right">(l)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><U>Effectiveness of Agreement</U>. The effectiveness of this
Agreement is contingent upon Executive&#146;s successful completion to the
satisfaction of the Company of a background check and drug test and Executive&#146;s
acknowledgement of the Company&#146;s policies. Further, this Agreement shall not
become effective until the Effective Date.</TD>
</TR>

</TABLE>


<P align="left" style="font-size: 12pt; text-indent: 4%">16.&nbsp;<U>Entire Agreement</U>. The Corporate Officer Separation Plan, the Change in Control
Agreement, the EICP, and this Agreement together constitute the entire agreement between the
parties regarding the subject matter of the Agreement, and it supersedes any oral or written
arrangements or understandings between the parties hereto with respect to the subject matter
hereof, including without limitation any term sheets or other similar presentations. In the event
of a conflict between this Agreement and the Change in Control Agreement, with the limited
exception of the definition of Cause contained in <U>Section&nbsp;7(b)</U> hereof, the terms of the
Change in Control Agreement shall prevail.


<P align="left" style="font-size: 12pt; text-indent: 4%">17.&nbsp;<U>Counterparts</U>. This Agreement may be executed in separate counterparts, any one of
which need not contain signatures of more than one party, but all of which taken together will
constitute one and the same Agreement. Signatures transmitted via facsimile or PDF will be deemed
the equivalent of originals.


<P align="center" style="font-size: 12pt">&#091;<I>Remainder of page left intentionally blank</I>&#093;



<P align="left" style="font-size: 12pt; text-indent: 4%">IN WITNESS WHEREOF, the parties have executed this Employment Agreement as of the day
and year first above written, to be effective as of the Effective Date.



<P align="left" style="margin-left:25%; font-size: 12pt"><B>CHARLES RIVER LABORATORIES INTERNATIONAL, INC.</B>



<P align="left" style="margin-left:25%; font-size: 12pt">By: /s/ David P. Johst<BR>
Name: David P. Johst<BR>
Title: Corporate Executive Vice President,<BR>
General Counsel & Chief Administrative<BR>
Officer<BR>



<P align="left" style="margin-left:29%; font-size: 12pt"><I>DULY AUTHORIZED BY AN AFFIRMATIVE VOTE OF
THE BOARD</I>



<P align="left" style="margin-left:25%; font-size: 12pt"><B>EXECUTIVE</B>



<P align="left" style="margin-left:25%; font-size: 12pt">By: /s/ James C. Foster


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 12pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Name: James C. Foster</TD>
</TR>

</TABLE>



<P align="center" style="font-size: 10pt; display: none">




<!-- v.121908 -->
</BODY>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>e44298-1844437152ebc1eefa_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 e44298-1844437152ebc1eefa_1.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  Z .$# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH *3('4BEKPC]H'PS\<]<\$3:A^SEX\\+>"/BYX>DD
MU/PQ!\1=$NO$?PJ\8O\ 9IHI?!_Q(TS2WM_$UEH&IR/;W,/B?P5J&F^+?#>I
MV-G=VDFKZ'-XB\)^)>C"4(XK$T,//$X?!QK5(TWB<4ZD<-0YW95*\J-*M4A2
M3MSSC2GR*\FN5-K#$UI8?#U:\*%;%2I0<_J^'5-UZJCJXT8U:E*$JEKN,'4C
MSM<J?,TCW?(]:8\B1JSNZ(B L[.P5551EF9B0%  )))  Y-?S4?%+_@KG_P5
M ^"TMYX)\?\ _!*+Q0_CNT7[(GB_PCJ'Q"\;_#/5+UE'EWFB77@SP3XDTS5;
M20O&YT^S^($M]!O6"[GM[@.B_"VK?"__ (+F_P#!6G7TT/XMVVO?LJ?L^ZC.
MB:QH6NZ5KWP2^'T&EB.P:]C;X?W5W<_&'XJRWB1&_P!+@\62ZUX576,P1Z[X
M2L;A);?]QRGP$SB=+^U>+.+^!.$.%X1=:>>U^*<GSQXF@DI+^R<NR/&XO$9C
MB*L7>CAG/#2J-."DJEH2_*<P\7LLC4_L_A_ASBOB+/925..54LBS'*U0JMJ+
M688O,\-0IX2E!_Q*JIUE%:M<MY+^K6+]KW]DZ3QFOP[C_:>_9ZD^(+:@-)'@
M=/C5\-V\8-JI?8-,'AE?$AUHWY<,GV,69N=ZE?*R#CZ,#HP!5E8'D$,""/4$
M'G\*_"_]FO\ X-^/V"/@KHME)\3?#&N_M(>.52VEO?$GQ&UC4](\-07:0".Z
MBT#P#X2U'2]&ATBYD_?+9^++GQKJ-NY(CUCRCLKV#]KRZ^('_!/3X.Q?%O\
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M5D8-<$,17T##;QP(D<,<<429"1QJ$1026^55"J,DD\ #/.,U\Y?L@?"7XG_
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M\+:S!]ITCQ-X3UO3?$?A_5;<2/$9]-UG2+B[TZ^A66.2(RVMQ*@D1T+!D8
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M:.WBSQ!\#_MX?L(^ /\ @WS_ &EOV!?VZ/\ @G/XS^)'P8^!?QC_ &P/A?\
MLI_M6_LSW_Q%\8^/? GQ"\(_$:WUW7;;4=.T_P 77^K:C>3V/A+PE\1HR_BK
M7]>FT+Q9)X$U_P ()H]Q8ZP;[^S#X-?\DA^%?_9./!'_ *C.F5_-K_P=A_\
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MV]U/\1?VEOVE/BMJGBII8"'DB=_A/KGPFT>^M;F8F26#6])U8ON:)I7C:1&
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M5:Z?[HHH KW=LEY:W-I(66.ZMYK:1DP'"3QM$Q4L&7<%8E=RL,XR".*^(/\
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M#6G1/(YMX-)\(6P0MYDQN)S)/)_4/10!^(O[$'_!"O\ 9W_9(^/T'[8?Q/\
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BH\T-OJ>M74%@MOH5J\5DD$<\ES,KW$GVI110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
